1 |
(2)-epigallocatechin-3-gallate (egcg) |
Epigallocatechin |
- |
- |
- |
008 [1] 8 💬 |
2 |
20 mg bid of pf-02545920 |
- |
- |
- |
- |
008 [1] 8 💬 |
3 |
20mg daily citalopram |
Citalopram |
[2] D00822 D00822, D07704 D07704 💬 |
SLC6A4 [1] SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
008 [1] 8 💬 |
4 |
5-chloro-1,2-dihydro-n-ethyl-4-hydroxy-1-methyl-2-oxo-n-phenyl-3-quinolinecarboxamide sodium |
- |
- |
- |
- |
008 [1] 8 💬 |
5 |
[123i]mni-420 |
- |
- |
- |
- |
006 [2] 6 , 8 💬 |
6 |
[18f]fpeb |
- |
- |
- |
- |
006 [3] 6 , 8 , 206 💬 |
7 |
Acr16 |
- |
- |
- |
- |
008 [1] 8 💬 |
8 |
Acr16 10 mg |
- |
- |
- |
- |
008 [1] 8 💬 |
9 |
Acr16 22.5 mg |
- |
- |
- |
- |
008 [1] 8 💬 |
10 |
Acr16 45 mg |
- |
- |
- |
- |
008 [1] 8 💬 |
11 |
Acr16 hydrochloride, asp2314 hydrochloride, fr310826 |
- |
- |
- |
- |
008 [1] 8 💬 |
12 |
Afq056 |
- |
- |
- |
- |
006 [3] 6 , 8 , 206 💬 |
13 |
Alprazolam |
Alprazolam |
[1] D00225 D00225 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
008 [1] 8 💬 |
14 |
Amantadine |
Amantadine |
[2] D00777 D00777, D07441 D07441 💬 |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
006 [4] 6 , 8 , 13, 127 💬 |
15 |
Anti-parkinson medication |
- |
- |
- |
- |
005 [5] 5 , 6 , 7 , 8 , 17 💬 |
16 |
Anx005 |
- |
- |
- |
- |
002 [3] 2 , 8 , 61 💬 |
17 |
Atomoxetine |
Atomoxetine |
[2] D02574 D02574, D07473 D07473 💬 |
SLC6A2 [1] SLC6A2 💬 |
Synaptic vesicle cycle [1] Synaptic vesicle cycle |
006 [3] 6 , 8 , 13 💬 |
18 |
Autologous stem cell |
- |
- |
- |
- |
008 [1] 8 💬 |
19 |
Bevantolol |
Bevantolol |
- |
- |
- |
008 [1] 8 💬 |
20 |
Bevantolol hydrochloride |
Bevantolol |
- |
- |
- |
008 [1] 8 💬 |
21 |
Biotin |
Biotin |
[1] D00029 D00029 💬 |
- |
- |
002 [5] 2 , 8 , 10, 13, 20 💬 |
22 |
Blood sample |
- |
- |
- |
- |
008 [13] 8 , 13, 46, 49, 51, 53, 61, 66, 84, 97, 274, 288, 299 💬 |
23 |
Bn82451b |
- |
- |
- |
- |
008 [1] 8 💬 |
24 |
Bn8251b |
- |
- |
- |
- |
008 [1] 8 💬 |
25 |
Bupropion |
Bupropion |
[3] D00817 D00817, D07591 D07591, D07938 D07938 💬 |
SLC6A2 [2] SLC6A2, SLC6A3 💬 |
Alcoholism [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
008 [5] 8 , 18, 21, 96, 171 💬 |
26 |
Calvan® 100 mg |
- |
- |
- |
- |
008 [1] 8 💬 |
27 |
Cannabidiol |
Cannabidiol |
[1] D10915 D10915 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
006 [17] 6 , 8 , 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 226, 271 💬 |
28 |
Cbd |
- |
- |
- |
- |
002 [11] 2 , 6 , 8 , 13, 46, 140, 144, 145, 156, 158, 206 💬 |
29 |
Cellavita hd higher dose |
- |
- |
- |
- |
008 [1] 8 💬 |
30 |
Cellavita hd lower dose |
- |
- |
- |
- |
008 [1] 8 💬 |
31 |
Cellavita-hd |
- |
- |
- |
- |
008 [1] 8 💬 |
32 |
Citalopram |
Citalopram |
[2] D00822 D00822, D07704 D07704 💬 |
SLC6A4 [1] SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
006 [6] 6 , 8 , 13, 18, 46, 127 💬 |
33 |
Ckd-504 |
- |
- |
- |
- |
008 [1] 8 💬 |
34 |
Coenzyme q10 |
Ubidecarenone |
[1] D01065 D01065 💬 |
- |
- |
002 [12] 2 , 5 , 6 , 8 , 10, 18, 46, 57, 113, 193, 214, 215 💬 |
35 |
Coq10 |
- |
- |
- |
- |
005 [3] 5 , 6 , 8 💬 |
36 |
Creatine |
Creatine |
- |
- |
- |
001 [12] 1 , 2 , 5 , 6 , 8 , 13, 46, 49, 50, 113, 156, 201 💬 |
37 |
Creatine monohydrate |
Creatine |
- |
- |
- |
002 [4] 2 , 8 , 113, 156 💬 |
38 |
Cystagon |
- |
- |
- |
- |
008 [3] 8 , 19, 299 💬 |
39 |
Cysteamine |
Cysteamine |
[2] D03634 D03634, D03635 D03635 💬 |
- |
- |
008 [4] 8 , 19, 21, 299 💬 |
40 |
Cysteamine bitartrate |
Cysteamine |
[2] D03634 D03634, D03635 D03635 💬 |
- |
- |
008 [4] 8 , 19, 21, 299 💬 |
41 |
Delta-9-tetrahydrocannabinol |
Dronabinol |
[1] D00306 D00306 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
008 [2] 8 , 13 💬 |
42 |
Delta-9-tetrahydrocannabinol (thc) and cannabidiol (cbd) |
Cannabidiol |
[2] D00306 D00306, D10915 D10915 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
008 [1] 8 💬 |
43 |
Deutetrabenazine |
Deutetrabenazine |
[1] D10701 D10701 💬 |
SLC18A2 [1] SLC18A2 💬 |
Alcoholism [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle |
008 [1] 8 💬 |
44 |
Deutetrabenazine oral tablet [austedo] |
Deutetrabenazine |
[1] D10701 D10701 💬 |
SLC18A2 [1] SLC18A2 💬 |
Alcoholism [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle |
008 [1] 8 💬 |
45 |
Device: biostamp npoint device |
- |
- |
- |
- |
008 [1] 8 💬 |
46 |
Device: deep brain stimulation |
- |
- |
- |
- |
005 [5] 5 , 6 , 7 , 8 , 17 💬 |
47 |
Dextromethorphan |
Dextromethorphan |
[3] D00848 D00848, D03742 D03742, D03744 D03744 💬 |
GRIN1 [6] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 [11] 2 , 6 , 8 , 13, 21, 46, 78, 85, 96, 97, 156 💬 |
48 |
Dextromethorphan/quinidine 20mg/10mg (dm/q 20mg/10mg) |
Dextromethorphan |
[7] D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 [11] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes [22] Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
008 [1] 8 💬 |
49 |
Digoxin |
Digoxin |
[1] D00298 D00298 💬 |
ATP1A1 [4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 |
Adrenergic signaling in cardiomyocytes [18] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway |
008 [3] 8 , 46, 210 💬 |
50 |
Dimebon |
Latrepirdine |
[1] D09917 D09917 💬 |
ACHE [6] ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [22] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 [1] 8 💬 |
51 |
Dimebon (latrepirdine) |
Latrepirdine |
[1] D09917 D09917 💬 |
ACHE [6] ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [22] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 [1] 8 💬 |
52 |
Dimebon + dextromethorphan |
Dextromethorphan |
[4] D00848 D00848, D03742 D03742, D03744 D03744, D09917 D09917 💬 |
ACHE [7] ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism [22] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 [1] 8 💬 |
53 |
Dimebon + ketoconazole |
Ketoconazole |
[2] D00351 D00351, D09917 D09917 💬 |
ACHE [7] ACHE, CYP17A1, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [28] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Cortisol synthesis and secretion, Cushing syndrome, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotine addiction, Ovarian steroidogenesis, Pathways of neurodegeneration - multiple diseases, Prion disease, Prolactin signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Steroid hormone biosynthesis, Systemic lupus erythematosus, cAMP signaling pathway |
008 [1] 8 💬 |
54 |
Dimebon + omeprazole |
Latrepirdine |
[5] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261, D09917 D09917 💬 |
ACHE [8] ACHE, ATP4A, ATP4B, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [26] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Dopaminergic synapse, Gastric acid secretion, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotine addiction, Oxidative phosphorylation, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 [1] 8 💬 |
55 |
Dimebon alone |
Latrepirdine |
[1] D09917 D09917 💬 |
ACHE [6] ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [22] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 [1] 8 💬 |
56 |
Dimebon dihydrochloride |
Latrepirdine |
[1] D09917 D09917 💬 |
ACHE [6] ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [22] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 [1] 8 💬 |
57 |
Dimebon ir |
Latrepirdine |
[1] D09917 D09917 💬 |
ACHE [6] ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [22] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 [1] 8 💬 |
58 |
Dimebon ir tablet |
Latrepirdine |
[1] D09917 D09917 💬 |
ACHE [6] ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [22] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 [1] 8 💬 |
59 |
Dimebon mr1 |
Latrepirdine |
[1] D09917 D09917 💬 |
ACHE [6] ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [22] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 [1] 8 💬 |
60 |
Dimebon mr2 |
Latrepirdine |
[1] D09917 D09917 💬 |
ACHE [6] ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [22] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 [1] 8 💬 |
61 |
Dimebon mr3 |
Latrepirdine |
[1] D09917 D09917 💬 |
ACHE [6] ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [22] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 [1] 8 💬 |
62 |
Dimebon mr4 |
Latrepirdine |
[1] D09917 D09917 💬 |
ACHE [6] ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [22] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 [1] 8 💬 |
63 |
Dimebon transdermal |
Latrepirdine |
[1] D09917 D09917 💬 |
ACHE [6] ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [22] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 [1] 8 💬 |
64 |
Divalproex |
- |
- |
- |
- |
008 [1] 8 💬 |
65 |
Dm |
- |
- |
- |
- |
006 [2] 6 , 8 💬 |
66 |
Egcg |
Epigallocatechin gallate |
- |
- |
- |
006 [9] 6 , 8 , 13, 17, 28, 85, 113, 206, 299 💬 |
67 |
Epa |
- |
- |
- |
- |
008 [6] 8 , 46, 48, 49, 113, 301 💬 |
68 |
Epigallocatechin |
Epigallocatechin |
- |
- |
- |
008 [5] 8 , 13, 28, 85, 113 💬 |
69 |
Ethyl icosapent |
Icosapent |
[1] D08061 D08061 💬 |
- |
- |
008 [1] 8 💬 |
70 |
Ethyl-epa |
Icosapent ethyl |
[1] D01892 D01892 💬 |
- |
- |
008 [1] 8 💬 |
71 |
Ethyl-epa (miraxion™) |
Icosapent ethyl |
[1] D01892 D01892 💬 |
- |
- |
008 [1] 8 💬 |
72 |
Ethyl-icosapent |
Icosapent |
[1] D08061 D08061 💬 |
- |
- |
008 [1] 8 💬 |
73 |
Fenofibrate |
Fenofibrate |
[1] D00565 D00565 💬 |
PPARA [1] PPARA 💬 |
Adipocytokine signaling pathway [8] Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway |
008 [5] 8 , 79, 93, 94, 265 💬 |
74 |
Graft intracerebral of foetal neurons |
- |
- |
- |
- |
008 [1] 8 💬 |
75 |
Gsk356278 |
- |
- |
- |
- |
008 [1] 8 💬 |
76 |
Haloperidol |
Haloperidol |
[2] D00136 D00136, D01898 D01898 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
008 [1] 8 💬 |
77 |
High doses of thiamine y biotin |
Biotin |
[2] D00029 D00029, D08580 D08580 💬 |
- |
- |
008 [1] 8 💬 |
78 |
Hyperium |
Rilmenidine |
[1] D08482 D08482 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
008 [1] 8 💬 |
79 |
Icosapent |
Icosapent |
[1] D08061 D08061 💬 |
- |
- |
008 [1] 8 💬 |
80 |
Isis 443139 10 mg |
- |
- |
- |
- |
008 [1] 8 💬 |
81 |
Isis 443139 120 mg |
- |
- |
- |
- |
008 [1] 8 💬 |
82 |
Isis 443139 30 mg |
- |
- |
- |
- |
008 [1] 8 💬 |
83 |
Isis 443139 60 mg |
- |
- |
- |
- |
008 [1] 8 💬 |
84 |
Isis 443139 90 mg |
- |
- |
- |
- |
008 [1] 8 💬 |
85 |
Ketoconazole |
Ketoconazole |
[1] D00351 D00351 💬 |
CYP17A1 [1] CYP17A1 💬 |
Cortisol synthesis and secretion [6] Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis |
008 [3] 8 , 13, 75 💬 |
86 |
Laquinimod |
Laquinimod |
- |
- |
- |
008 [4] 8 , 13, 49, 96 💬 |
87 |
Laquinimod capsules 0.5 mg |
Laquinimod |
- |
- |
- |
008 [2] 8 , 96 💬 |
88 |
Latrepirdine |
Latrepirdine |
[1] D09917 D09917 💬 |
ACHE [6] ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [22] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 [1] 8 💬 |
89 |
Lax-101 |
LAX-101 |
- |
- |
- |
008 [1] 8 💬 |
90 |
Lithium |
- |
- |
- |
- |
002 [5] 2 , 5 , 6 , 7 , 8 💬 |
91 |
Melatonin |
Melatonin |
[1] D08170 D08170 💬 |
MTNR1A [2] MTNR1A, MTNR1B 💬 |
Circadian entrainment [2] Circadian entrainment, Neuroactive ligand-receptor interaction |
006 [11] 6 , 8 , 13, 46, 49, 90, 97, 144, 145, 149, 202 💬 |
92 |
Memantine |
Memantine |
[2] D04905 D04905, D08174 D08174 💬 |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 [7] 2 , 6 , 8 , 13, 49, 127, 205 💬 |
93 |
Minocycline |
Minocycline |
[2] D00850 D00850, D05045 D05045 💬 |
- |
- |
002 [13] 2 , 6 , 8 , 13, 46, 85, 90, 94, 162, 201, 206, 280, 299 💬 |
94 |
Moderate doses of thiamine y biotin |
Biotin |
[2] D00029 D00029, D08580 D08580 💬 |
- |
- |
008 [1] 8 💬 |
95 |
N.a. |
- |
- |
- |
- |
003 [10] 3 , 6 , 8 , 13, 46, 96, 97, 240, 256, 271 💬 |
96 |
Neflamapimod |
Neflamapimod |
[1] D10959 D10959 💬 |
MAPK11 [4] MAPK11, MAPK12, MAPK13, MAPK14 💬 |
AGE-RAGE signaling pathway in diabetic complications [58] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dopaminergic synapse, Endocrine resistance, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hepatitis B, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, MAPK signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oocyte meiosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Relaxin signaling pathway, Retrograde endocannabinoid signaling, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Yersinia infection |
008 [1] 8 💬 |
97 |
Nilotinib |
Nilotinib |
[1] D08953 D08953 💬 |
ABL1 [4] ABL1, KIT, PDGFRA, PDGFRB 💬 |
Acute myeloid leukemia [32] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
006 [5] 6 , 8 , 34, 51, 86 💬 |
98 |
Nilotinib 150 mg |
Nilotinib |
[1] D08953 D08953 💬 |
ABL1 [4] ABL1, KIT, PDGFRA, PDGFRB 💬 |
Acute myeloid leukemia [32] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
008 [1] 8 💬 |
99 |
Olanzapine |
Olanzapine |
[2] D00454 D00454, D06623 D06623 💬 |
ADRA1A [11] ADRA1A, ADRA1B, ADRA1D, DRD2, DRD3, DRD4, HRH1, HTR2A, HTR2B, HTR2C, HTR6 💬 |
AMPK signaling pathway [16] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Salivary secretion, Serotonergic synapse, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 [2] 2 , 8 💬 |
100 |
Omeprazole |
Omeprazole |
[4] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
006 [16] 6 , 8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬 |
101 |
Oms643762 |
- |
- |
- |
- |
008 [1] 8 💬 |
102 |
Osu6162 similar to (-)-osu 6162 |
- |
- |
- |
- |
006 [2] 6 , 8 💬 |
103 |
Other: 31-phosphorus rmn spectroscopy |
Phosphorus |
- |
- |
- |
008 [1] 8 💬 |
104 |
Pbf-999 |
- |
- |
- |
- |
008 [1] 8 💬 |
105 |
Pbf-999 / 160 mg |
- |
- |
- |
- |
008 [1] 8 💬 |
106 |
Pbf-999 / 320 mg |
- |
- |
- |
- |
008 [1] 8 💬 |
107 |
Pbt2 |
- |
- |
- |
- |
008 [1] 8 💬 |
108 |
Pf-02545920 |
- |
- |
- |
- |
008 [1] 8 💬 |
109 |
Phenylbutyrate |
Phenylbutyric acid |
[1] D05868 D05868 💬 |
- |
- |
002 [11] 2 , 3 , 6 , 8 , 15, 93, 94, 244, 251, 297, 299 💬 |
110 |
Phosphorus |
Phosphorus |
- |
- |
- |
008 [1] 8 💬 |
111 |
Pl101 |
- |
- |
- |
- |
008 [1] 8 💬 |
112 |
Pridiopidine |
- |
- |
- |
- |
008 [1] 8 💬 |
113 |
Pridopidina |
- |
- |
- |
- |
008 [1] 8 💬 |
114 |
Pridopidine |
Pridopidine |
[1] D09953 D09953 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 [3] 2 , 6 , 8 💬 |
115 |
Pridopidine (90 mg) |
Pridopidine |
[1] D09953 D09953 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
008 [1] 8 💬 |
116 |
Pridopidine hydrochloride |
Pridopidine |
[1] D09953 D09953 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
008 [1] 8 💬 |
117 |
Quinidine |
Quinidine |
[4] D00642 D00642, D00643 D00643, D02272 D02272, D08458 D08458 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
002 [3] 2 , 8 , 13 💬 |
118 |
Ramelteon |
Ramelteon |
[1] D02689 D02689 💬 |
MTNR1A [2] MTNR1A, MTNR1B 💬 |
Circadian entrainment [2] Circadian entrainment, Neuroactive ligand-receptor interaction |
006 [3] 6 , 8 , 46 💬 |
119 |
Resveratrol |
Resveratrol |
- |
- |
- |
002 [6] 2 , 8 , 18, 89, 113, 299 💬 |
120 |
Rg6042, formerly isis 443139, ionis-httrx |
- |
- |
- |
- |
008 [1] 8 💬 |
121 |
Rilmenidine |
Rilmenidine |
[1] D08482 D08482 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
008 [1] 8 💬 |
122 |
Riluzole |
Riluzole |
[1] D00775 D00775 💬 |
GRIA1 [14] GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [23] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway |
002 [8] 2 , 3 , 5 , 8 , 13, 17, 18, 206 💬 |
123 |
Risperidone |
Risperidone |
[1] D00426 D00426 💬 |
DRD2 [2] DRD2, HTR2A 💬 |
Alcoholism [11] Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway |
008 [5] 8 , 156, 179, 187, 206 💬 |
124 |
Ro 723-4292/f02 |
- |
- |
- |
- |
008 [1] 8 💬 |
125 |
Ro7234292 |
- |
- |
- |
- |
008 [1] 8 💬 |
126 |
Ro7234292 (rg6042) |
- |
- |
- |
- |
008 [1] 8 💬 |
127 |
Rolipram |
Rolipram |
[1] D01783 D01783 💬 |
PDE4A [4] PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways [5] Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
008 [2] 8 , 13 💬 |
128 |
Rp 103 |
- |
- |
- |
- |
008 [2] 8 , 19 💬 |
129 |
Rp103 |
- |
- |
- |
- |
008 [2] 8 , 19 💬 |
130 |
Sage-718 |
- |
- |
- |
- |
006 [2] 6 , 8 💬 |
131 |
Sbt-020 |
- |
- |
- |
- |
008 [1] 8 💬 |
132 |
Sd-809 |
- |
- |
- |
- |
008 [1] 8 💬 |
133 |
Selisistat |
Selisistat |
- |
- |
- |
008 [1] 8 💬 |
134 |
Sen0014196 |
- |
- |
- |
- |
008 [1] 8 💬 |
135 |
Sen0014196 (high dose) |
- |
- |
- |
- |
008 [1] 8 💬 |
136 |
Sen0014196 (low dose) |
- |
- |
- |
- |
008 [1] 8 💬 |
137 |
Sodium phenylbutyrate |
Phenylbutyric acid |
[1] D05868 D05868 💬 |
- |
- |
002 [4] 2 , 3 , 8 , 251 💬 |
138 |
Som3355 100mg bid |
- |
- |
- |
- |
008 [1] 8 💬 |
139 |
Som3355 200mg bid |
- |
- |
- |
- |
008 [1] 8 💬 |
140 |
Srx246 |
- |
- |
- |
- |
008 [1] 8 💬 |
141 |
Ss-20 |
- |
- |
- |
- |
008 [1] 8 💬 |
142 |
Tetrabenazine |
Tetrabenazine |
[1] D08575 D08575 💬 |
SLC18A2 [1] SLC18A2 💬 |
Alcoholism [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle |
008 [1] 8 💬 |
143 |
Tetrabenazine withdrawal |
Tetrabenazine |
[1] D08575 D08575 💬 |
SLC18A2 [1] SLC18A2 💬 |
Alcoholism [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle |
008 [1] 8 💬 |
144 |
Tetrahydrocannabinol |
Dronabinol |
[1] D00306 D00306 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
008 [3] 8 , 13, 298 💬 |
145 |
Thc |
- |
- |
- |
- |
008 [4] 8 , 13, 46, 96 💬 |
146 |
Thiamine |
Thiamine |
[1] D08580 D08580 💬 |
- |
- |
008 [3] 8 , 13, 265 💬 |
147 |
Tiapridal |
- |
- |
- |
- |
008 [1] 8 💬 |
148 |
Tominersen |
- |
- |
- |
- |
008 [1] 8 💬 |
149 |
Triheptanoin |
Triheptanoin |
[1] D11465 D11465 💬 |
- |
- |
002 [9] 2 , 8 , 149, 156, 248, 256, 257, 317, 324 💬 |
150 |
Triheptanoin 1g/kg/day |
Triheptanoin |
[1] D11465 D11465 💬 |
- |
- |
008 [1] 8 💬 |
151 |
Triheptanoin oil |
Triheptanoin |
[1] D11465 D11465 💬 |
- |
- |
008 [1] 8 💬 |
152 |
Tv-5600 |
- |
- |
- |
- |
008 [3] 8 , 13, 96 💬 |
153 |
Tv-7820 |
- |
- |
- |
- |
008 [1] 8 💬 |
154 |
Ubiquinol |
Ubiquinol |
- |
- |
- |
006 [3] 6 , 8 , 17 💬 |
155 |
Ursodiol |
Ursodeoxycholic acid |
[1] D00734 D00734 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
008 [6] 8 , 20, 93, 97, 234, 299 💬 |
156 |
Ux007 |
- |
- |
- |
- |
008 [4] 8 , 248, 256, 257 💬 |
157 |
Valbenazine |
Valbenazine |
[1] D10675 D10675 💬 |
SLC18A2 [1] SLC18A2 💬 |
Alcoholism [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle |
008 [1] 8 💬 |
158 |
Vx-745 |
- |
- |
- |
- |
008 [1] 8 💬 |
159 |
Vx15/2503 |
- |
- |
- |
- |
008 [2] 8 , 13 💬 |
160 |
Warfarin |
Warfarin |
[3] D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 [2] NQO1, VKORC1 💬 |
Biosynthesis of cofactors [6] Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
006 [11] 6 , 8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬 |
161 |
Wve-120101 |
- |
- |
- |
- |
008 [1] 8 💬 |
162 |
Wve-120102 |
- |
- |
- |
- |
008 [1] 8 💬 |
163 |
Xenazine |
- |
- |
- |
- |
008 [1] 8 💬 |
164 |
Zoloft |
- |
- |
- |
- |
008 [1] 8 💬 |